论文信息 - First results from a phase I trial of AZD8055, a dual mTORC1 and mTORC2 inhibitor. - 字舞流文

First results from a phase I trial of AZD8055, a dual mTORC1 and mTORC2 inhibitor.

E. Raymond | R. Kurzrock | A. Naing | U. Banerji | S. Kaye | C. Aghajanian | L. Grinsted | E. Oelmann | W. Burke | M. Blanco-Codesido